Advanced Biomed Inc.
ADVB
$4.95
$0.4910.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.95% | -70.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.30% | -56.79% | |||
| Operating Income | 24.30% | 56.79% | |||
| Income Before Tax | 1,909.82% | 44.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1,909.82% | 44.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,872.53% | 44.85% | |||
| EBIT | 24.30% | 56.79% | |||
| EBITDA | 20.34% | 58.55% | |||
| EPS Basic | 1,872.43% | 44.75% | |||
| Normalized Basic EPS | 10.96% | 44.83% | |||
| EPS Diluted | 1,872.43% | 44.75% | |||
| Normalized Diluted EPS | 10.96% | 44.83% | |||
| Average Basic Shares Outstanding | 0.00% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||